Advertisement
Singapore markets close in 6 hours 54 minutes

  • Straits Times Index

    3,262.10
    -31.03 (-0.94%)
     

  • Nikkei

    37,781.41
    -678.67 (-1.76%)
     

  • Hang Seng

    17,167.79
    -33.48 (-0.19%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Bitcoin USD

    63,999.13
    -2,707.13 (-4.06%)
     

  • CMC Crypto 200

    1,391.23
    -32.87 (-2.31%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Gold

    2,330.50
    -7.90 (-0.34%)
     

  • Crude Oil

    82.63
    -0.18 (-0.22%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • FTSE Bursa Malaysia

    1,572.69
    +1.21 (+0.08%)
     

  • Jakarta Composite Index

    7,174.53
    -7,110.81 (-49.78%)
     

  • PSE Index

    6,582.89
    +10.14 (+0.15%)
     

Avanir Pharmaceuticals (AVNR) in Focus: Stock Moves 6.1% Higher

Zacks Equity Research

Avanir Pharmaceuticals, Inc. (AVNR) was a big mover last session, as the company saw its shares rise by over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained almost 59% since Apr 28.

This drugs manufacturer has seen one positive and one negative estimate revision over the past 30 days and its Zacks Consensus Estimate has gone down over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Avanir Pharmaceuticals has a Zacks Rank #2 (Buy) while its Earnings ESP is positive.

Some better-ranked stocks in the same industry include Biomerica Inc. (BMRA), Bio-Path Holdings, Inc. (BPTH) and POZEN Inc. (POZN). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




AVANIR PHARMACEUTICALS INC (AVNR): Free Stock Analysis Report

BIOMERICA INC (BMRA): Free Stock Analysis Report

BIO PATH HOLDINGS INC (BPTH): Free Stock Analysis Report

POZEN INC (POZN): Free Stock Analysis Report


Zacks Investment Research